Drugs / SCH-1
last change Mar 2022 re-read 3 minutes ago

SCH-1

Developed for
acute conjunctivitis
Investigated by
Sacsh

Trials 1

202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT05356793 Mar 2021 → Mar 2022 acute conjunctivitis Sacsh Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as SCH-1 ClinicalTrials.gov intervention name — accepted as the source's own label NCT05356793 ↗